Journal
TRENDS IN PHARMACOLOGICAL SCIENCES
Volume 31, Issue 6, Pages 284-295Publisher
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tips.2010.03.001
Keywords
-
Categories
Funding
- National Institutes of Health [EY009339, P30 EY11373]
- Foundation Fighting Blindness
Ask authors/readers for more resources
Knowledge about retinal photoreceptor signal transduction and the visual cycle required for normal eyesight has increased exponentially over the past decade. Substantial progress in human genetics has facilitated the identification of candidate genes and complex networks underlying inherited retinal diseases. Natural mutations in animal models that mimic human diseases have been characterized and advanced genetic manipulation can now be used to generate small mammalian models of human retinal diseases. Pharmacological repair of defective visual processes in animal models not only validates their involvement in vision, but also provides great promise for the development of improved therapies for millions who are progressing towards blindness or are almost completely robbed of their eyesight.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available